Digital Health June 7, 2024
The first patient in England has been treated with a personalised vaccine against bowel cancer, in a clinical trial as part of NHS England’s Cancer Vaccine Launch Pad.
The launch pad, created in partnership with Genomics England, is a platform that aims to speed up access to messenger ribonucleic acid (mRNA) personalised cancer vaccine clinical trials for people who have been diagnosed with cancer.
Through the platform, people with cancer who are receiving treatment in the NHS in England can be assessed to see if they might be eligible to join a cancer vaccine clinical trial, and then referred to a hospital that is running a trial.
To date 30 hospitals in England have signed up to the Cancer Vaccine...
Today's Sponsors
Today's Sponsor